Comparison of Culture Media for in Vitro Embryo Development
Completed · Not applicable
Conditions studied: Infertility
In brief
The purpose of this study is to collect development and outcome data on human embryos which are cultured in a 2nd generation continuous single culture medium (CSCM2) with the objective to demonstrate its performance efficacy in comparison to existing commercially available single culture or continuous embryo culture media.
Key facts
- Study ID
- NCT02846012
- Run by
- Ovation Fertility
- People needed
- 45
- Starts
- 2016-05-01
- Expected to finish
- 2017-12-22
- Last updated by the study team
- 2017-12-27
Who can join
Age: 18 and older, up to 51. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years of age in good general physical and mental health.
- Women undergoing fresh in vitro fertilization treatment using their own eggs which will be fertilized by ICSI only
- Normal uterine cavity, as defined by the program.
- Normal BMI (< 35).
- Normal endocrine workup (including PCOS patients).
- Fresh or Frozen Blastocyst transfer
- At least 4 diploid zygotes showing signs of normal (2PN) fertilisation
- Willing to have half of their 2PN embryos cultured in CSCM and the other half of their 2PN embryos cultured in CSCM 2nd generation
- Willing to comply with study protocol and procedures
- Willing to provide written informed consent
You may not qualify if…
- Use of donor egg / gestational carrier
- Couples for whom the male partner requires surgically extracted sperm (testicular or epididymal retrieval)
- History of complications related to tolerance to OCP's, Gonadotropins, Progesterone or estrogen.
- A medical condition that is contraindicated to pregnancy or gonadotropin therapy (eg. allergies, immune deficiency, etc.)
- History of cancer
Where it is running
- Ovation Fertility - Austin — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.